PIC/S reviews deficiencies found during inspections of API manufacturing facilities, harmonizes GMP standards, and provides training for inspectors worldwide.
Alicia Mozzachio
Advertisement
Alicia Mozzachio, branch chief, Division of International Drug Quality, US FDA, CDER/Office of Compliance/Office of Manufacturing and Product Quality.
Articles by Alicia Mozzachio
PIC/S reviews deficiencies found during inspections of API manufacturing facilities, harmonizes GMP standards, and provides training for inspectors worldwide.
Advertisement
Latest Updated Articles
- Deficiencies Found in API Inspections
Published: December 2nd 2013 | Updated:
- Deficiencies Discovered in API Inspections Suggest Strategies for Improvement
Published: December 2nd 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
2
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
3
AAPS PharmSci 360 2025: Trends in Bioanalysis
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
